ArticleEcancermedicalscience2025

Excellent response to trametinib and low dose chemotherapy in a patient with rare RAF1 mutated sarcoma in a tertiary care center in India.

Anjali Govind et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.